BiotechTube
Home/Incyte/Bill Meury
BM

Bill Meury

President and Chief Executive Officer

Incyte

Therapeutic Areas

HematologyOncologyInflammation and AutoimmunityDermatology

Incyte Pipeline

DrugIndicationPhase
Zynyz® (retifanlimab)Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)Approved
Tabrecta® (capmatinib)METex14 Skipping Advanced Non-Small Cell Lung CancerApproved
Opzelura™ (ruxolitinib) creamVitiligo and other dermatological conditionsApproved

Leadership Team at Incyte

PJ
Pablo J. Cagnoni, M.D.
President, Head of Research and Development
SB
Soni Basi, Ph.D.
Executive Vice President and Chief Human Resources Officer
View full Incyte profile